Wildfire PM2.5 differs from routine air pollution by composition, with higher elemental and organic carbon fractions that ...

Learn the single-leg stand in the Balance Exercise Package for patients with cancer to improve stability, strengthen balance ...

FDA approval covers PIK3CA–wild-type HR+/HER2− advanced breast cancer progressing after ≥1 metastatic endocrine line, positioning gedatolisib as a post-endocrine targeted option with fulvestrant ± ...

Maggie A. Smith, DNP, MSN/Ed, RN, OCN is Field Medical Director in GU Oncology at Pfizer, and Director-at-Large for the national Oncology Nursing Society (ONS), as well as Nominating-Chair and ...

Patricia McCrink, MSN, RN, CRT, of Miami Cancer Institute, completed treatment for stage IV non-Hodgkin lymphoma and returned to nursing with a deeper capacity for compassion and patient advocacy.

Focal cryotherapy is changing prostate cancer care. Dr. Herbert Lepor explains this milestone treatment and what it means for patients.

Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...

Patricia McCrink’s 30+ years in oncology nursing are distinguished by sustained bedside presence, emotional support, and ...

Chermaine Wulff of Valley Medical Center goes beyond clinical duties to champion her patients' final wishes, advocate for nursing staff and strengthen oncology nursing across the Pacific Northwest.

Focal cryotherapy is changing prostate cancer care. Dr. Herbert Lepor explains this milestone treatment and what it means for patients. For decades, men diagnosed with prostate cancer faced two ...

Traditional approval establishes confirmed clinical benefit for selpercatinib in tumor-agnostic RET fusion–positive solid tumors after progression or when no satisfactory options exist. LIBRETTO-001 ...